Myriad Genetics Inc (MYGN)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 837,600 | 823,600 | 802,200 | 774,200 | 753,200 | 734,400 | 698,900 | 694,700 | 678,400 | 661,400 | 672,300 | 682,400 | 690,600 | 684,400 | 662,300 | 566,100 | 557,000 | 597,500 | 638,600 | 760,800 |
| Property, plant and equipment | US$ in thousands | — | — | — | — | — | — | 218,600 | 203,300 | 187,300 | 178,100 | 135,700 | 116,600 | 125,300 | 127,000 | 129,800 | 45,100 | 100,400 | 36,700 | 103,000 | 37,100 |
| Fixed asset turnover | — | — | — | — | — | — | 3.20 | 3.42 | 3.62 | 3.71 | 4.95 | 5.85 | 5.51 | 5.39 | 5.10 | 12.55 | 5.55 | 16.28 | 6.20 | 20.51 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $837,600K ÷ $—K
= —
The fixed asset turnover ratio for Myriad Genetics Inc has shown significant fluctuations over the period from March 31, 2020, to June 30, 2024.
Initially, the company demonstrated a very high fixed asset turnover ratio of 20.51 on March 31, 2020, indicating that the company was generating a high level of revenue in relation to its investment in fixed assets. However, this ratio decreased substantially to 6.20 on June 30, 2020, reflecting a decline in the efficiency of utilizing fixed assets to generate revenue.
Subsequently, there were fluctuations in the fixed asset turnover ratio, varying between 5.10 and 16.28 from June 2020 to December 2021. These fluctuations suggest changes in the company's ability to efficiently utilize its fixed assets during this period.
From March 31, 2022, to June 30, 2024, the fixed asset turnover ratio exhibited a decreasing trend, falling from 5.85 to 4.95. This downward trend indicates that the company may be facing challenges in optimizing the productivity of its fixed assets to generate revenue.
It is noteworthy that the data is incomplete for the period from September 30, 2023, to December 31, 2024, with "—" indicating missing information for these quarters.
Overall, the analysis of Myriad Genetics Inc's fixed asset turnover ratio highlights both periods of high efficiency in utilizing fixed assets to generate revenue and potential challenges in maintaining or improving this efficiency over the period under review.
Peer comparison
Dec 31, 2024